News and Events See us in Globeshttp://www.globes.co.il/news/article.aspx?did=1000592025SoluBest and Dr. Reddy´s Sign Drug Delivery Collaboration to Develop New, Proprietary Formulations Ness Ziona, October 4, 2010 -- SoluBest has closed a collaboration agreement with Dr. Reddy's Laboratories Ltd. (Hyderabad, India) to develop a new, proprietary formulation of one of SoluBest’s pipeline compounds. In return, SoluBest is eligible to upfront, research and milestone and significant royalty payments.SoluBest to present at Medica and Ernst & Young's JOURNEY 2010 conference, October 26th, Hilton Tel AvivSoluBest's CEO will be lecturing about "Business Development on a Shoestring". Details to follow.SoluBest to present at Bio-Partnering Europe, Oct. 10-12th, LondonSoluBest selected to present at Bio-Partnering Europe, Oct. 10-12th, London. Come see Dr. Amir Zalcenstein present SoluBest's technology and business model at the Abbey Room West, 4th Floor, QE II conference center, Tuesday 13th of October, at 14:45. See you there!Dr. Amir Zalcenstein, MBA, appointed SoluBest's CEOSee press releaseDr. Yoram Sela, Dr. Phil Smith and Dr. Blair West join SoluBest's Scientific Advisory BoardSee "about us"SoluBest featured in the oral delivery issue of ON Drug DeliveryDr. John Siebert and Dr. Rodney Kasan join SoluBest's board of directorsSee our board page
http://www.globes.co.il/news/article.aspx?did=1000592025
SoluBest's CEO will be lecturing about "Business Development on a Shoestring".
Details to follow.
SoluBest selected to present at Bio-Partnering Europe, Oct. 10-12th, London.
Come see Dr. Amir Zalcenstein present SoluBest's technology and business model at the Abbey Room West, 4th Floor, QE II conference center, Tuesday 13th of October, at 14:45.
See you there!
See press release
See "about us"
See our board page
Unique Technology
SoluBest has developed a proprietary, drug delivery platform for significantly improving the bio-availability of poorly soluble drugs.
SoluBest’s proprietary Solumer™ Platform increases drug solubility by creating proprietary smart drug-polymer particles where drug molecules are uniquely interwoven within FDA-approved polymers. Once in the body, these formulations disintegrate into stable colloidal dispersions, significantly increasing drug solubility and oral absorption, thus improving the performance of insoluble active substances.
The Technology is:
♦ Validated & Proprietary
♦ Fast and Cost Effective
♦ Uses FDA approved polymers only
Complete Solutions
SoluBest has the capacity to help you through your most difficult formulation projects - from start to finish.
Our in house capabilities, coupled to our collaborators' capacities, allow us to carry out product development from concept to market:
Feasibility studies
Oral dosage form development
Scale up to pilot and industrial scale
Non GMP/ GLP production for preclinical trials
GMP production for clinical trials up to phase III